Aim: We evaluated the diagnostic impact of serum midkine (s-MK) levels in patients with gastric cancer using a monoclonal antibody enzyme-linked immunosorbent assay system (ELISA) to detect s-MK levels.
| INTRODUC TI ON
One example is midkine, expressed at higher levels in various solid tumors than in adjacent normal tissues, 5 even during early-stage disease. [6] [7] [8] Serum midkine (s-MK) levels reflect MK expression levels in cancer tissues because MK is a secreted cytokine. Based on meta-analysis, Jing et al 9 reported that s-MK level was an effective means of diagnosing cancer other than gastric cancer.
In previous studies, 10, 11 polyclonal antibodies were used in enzyme-linked immunosorbent assay (ELISA). Polyclonal antibody can bind to multiple epitopes; however, monoclonal antibody can bind to one specific epitope only. Generally, polyclonal antibody ELISA shows a relatively high positive rate but low specificity with high coefficient of variation. Indeed, the coefficient of variation of polyclonal antibody ELISA was 9.5% 12 and the coefficient of variation of monoclonal antibody ELISA was 2.4%-4.16%. 13, 14 Recently, an ELISA using monoclonal antibodies against midkine was developed. 13 We evaluated the diagnostic abilities of this assay system using monoclonal antibodies for malignant mesothelioma 15 and head and neck cancer. 16 Only two reports used polyclonal antibody ELISA to evaluate s-MK levels in patients with gastric cancer. 10, 11 However, clinicopathological significance of the s-MK levels was not evaluated in those studies.
Therefore, in the present study, we used monoclonal antibody ELISA 13 to evaluate the diagnostic impact of s-MK level. In addition,
we evaluated the clinicopathological and prognostic significance of s-MK levels in patients with gastric cancer. 
| SUBJEC TS AND ME THODS

| Subjects
| Statistical analyses
Data are expressed as means plus standard deviations. A paired ttest was used to make between-group comparisons. Kaplan-Meier product limit method was used to calculate the survival probabilities.
Log-rank test was used to test the differences between the groups.
Fisher's exact probability test was applied to determine the significance of differences between the two groups. Cox's proportional hazards model was used to assess the influence of each clinicopathological variable on survival. EZR statistical software was used to carry out all the statistical analyses. 18 Statistical significance was defined as P < 0.05.
| RE SULTS
Subjects were 87 males (66%) and 44 females (34%) with a median on peritoneal cytology (n = 6), and peritoneal metastasis (n = 6). As a result of passage disturbance or bleeding, these cases were treated with gastrectomy. For the entire population, the median follow-up period was 39 months.
| Comparison of serum midkine levels between gastric cancer patients and healthy controls
Serum midkine levels of gastric cancer patients (344 ± 565 pg/ mL) were significantly higher than those of the healthy controls (208 ± 107 pg/mL; P = 0.02). Based on the cut-off value of 421 pg/mL (mean + 2 SD in healthy controls), the positive rate of healthy and gastric cancer was 5% and 21%, respectively.
Sensitivity was 21%, specificity was 95%, positive predictive value was 85% negative predictive value was 48%, and accuracy was 53%. Table 1 shows the comparison of s-MK levels according to clinicopathological characteristics of patients with gastric cancer, including CEA and CA19-9. CEA was significantly associated with high s-MK.
| Comparison of serum midkine levels according to clinicopathological factors of patients with gastric cancer
Tumor depth was slightly associated with s-MK. Gender, age, CA19-9, lymph node metastasis, distant metastasis, and differentiation were not associated with s-MK. Multivariate analysis showed that CEA was an independent risk factor (P = 0.01) ( Table 1) . Smoking was significantly associated with CEA and s-MK. However, chronic inflammatory diseases, such as collagen disease, chronic hepatitis, empyema arthritis, chronic obstructive pulmonary disease (COPD), and diabetes mellitus,
were not associated with CEA (Table S1 ) and s-MK. Various inflammatory blood laboratory data, such as C-reactive protein (CRP), white blood cells, and neutrophils, were not associated with s-MK (Table S2) . Figure 3 shows the relationship between s-MK, CEA, and CA19-9 in patients with gastric cancer. Of the 131 patients, 18 patients were detected by s-MK only (Figure 3 ). In contrast, seven cases each were detected by CEA only or by CA19-9 only. The positive rate of s-MK was higher than that of both CEA and CA19-9. Number of s-MK positive cases (n = 28) was significantly greater than that of CEA positive cases (n = 19) (P < 0.01). The positive rate of combination of s-MK + CEA was 29% (n = 38) and of combination of s-MK + CA19-9 was also 29% (n = 38). These combinatory positive rates were significantly higher than those of CEA + CA19-9 (21%) (P < 0.01) (Table S3) .
Among s-MK positive cases, 17 were differentiated type and 11 
| Univariate and multivariate analysis of risk factors on survival
Patients with high s-MK showed worse overall survival than those with low s-MK. However, the difference was not statistically significant ( Figure 4) . The left panel of Table 2 shows the univariate analysis to determine the prognostic impact of clinicopathological factors. Gender, tumor depth, lymphatic metastasis, and distant metastasis were significantly correlated with survival by log-rank test.
In the multivariate analysis, gender, tumor depth, and presence of distant metastasis were significantly associated with poor survival;
however, s-MK was not found to be a significant prognostic factor (Table 2 , right panel).
| D ISCUSS I ON
We found that positive s-MK rate in patients with gastric cancer was significantly higher than that observed in healthy subjects. Although Although the difference of positive rates between polyclonal and monoclonal MK antibody is important, previous studies have not shown details of pathological data. 10, 11 Therefore, it was difficult to compare sensitivity and specificity between the two types of ELISA.
Moreover, previous polyclonal antibody ELISA is currently unavailable. Our argument was that we were using monoclonal antibodies to pursue high specificity.
Similar to previous reports on mesothelioma 15 and head and neck carcinoma, 16 In conclusion, s-MK levels increased, even during early stages of gastric cancer. In combination with s-MK, the positive rate of CEA + CA19-9 increased in the patients with stage I/II gastric cancer. Although high s-MK seemed to be a poor prognostic factor for patient survival, the difference was not statistically significant.
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